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CASE REPORT 
Rhodotorula fungaemia: a We-threatening complication of 
indwelling central venous catheters 
Rhodotorula-Fungamie: Eine lebensbedrohliche Komplikation bei 
zentralvenosen Verweilkathetern 
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Summary. A 30-year-old woman receiving total 
parenteral nutrition via an indwelling central 
venous catheter for an intestinal motility disorder 
developed fever, tachycardia, tachypnea, and 
hypotension. Multiple blood cultures drawn 
through the catheter prior to these events, as well 
as a peripheral blood culture obtained earlier, 
grew the red yeast Rhodotorula rubra. The patient 
was critically ill for over one month but eventu- 
ally recovered with therapy including the sys- 
temic antifungal agents amphotericin B and 
flucytosine and removal of the catheter. Although 
Rhodotorula has generally been regarded as having 
low pathogenicity, this case emphasizes the seri- 
ous nature of Rhodotorula sepsis and suggests the 
need for both systemic antifungal therapy and 
removal of a colonized indwelling catheter. 
Zusammenfassung. Eine 30-jahrige Frau, 
wegen einer intestinalen Motilitatsstorung uber 
einen zentralvenosen Verweilkatheter vollstandig 
parenteral ernahrungspflichtig, entwickelte 
Fieber, Tachykardie, Tachypnoe und Hypotonie. 
Aus mehrmaligen Blutkulturen, iiber den Kathe- 
ter vor dem Auftreten dieser Symptome gewon- 
nen, sowie aus einer davor angelegten peripheren 
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Blutkultur wurde die rote Hefe Rhodotorula rubra 
angeziichtet. Die Patientin verblieb iiber einen 
Monat lang in kritischem Zustand, erholte sich 
jedoch unter Therapie mit den systemischen Anti- 
mykotika Amphotericin B und Flucytosin und 
nach Entfernung des Katheters. Obgleich Rhodo- 
torula allgemein als nur geringgradig pathogen 
angesehen wird, belegt dieser Fall den ernsthaften 
Charakter der Rhodotorula-Sepsis sowie die Not- 
wendigkeit der systemischen Antimykotika- 
Therapie und der Entfernung des Katheters. 
Introduction 
Rhodotorula is a red-coloured yeast which has 
rarely been implicated as a cause of clinically 
significant infection in humans. With the 
expanded use of indwelling central venous cath- 
eters for administration of therapeutic and 
nutritional agents has come the observation of 
increased numbers of cases of catheter-associated 
fungaemia with Rhodotorula species [ 1, 21. 
Additionally, several cases of infection involving 
invasion of tissues have been reported, including 
cases in which Rhodotorula has been cultured from 
an aortic valve, cerebrospinal fluid, and bone 
marrow [3-51. In general, this yeast has been 
felt to be of low pathogenicity, with only two 
deaths thought to be related to fungal infection 
among those with culture-proven fungaemia 
[2-41. This has led to uncertainty regarding the 
need to treat persons found to have Rhodotorula 
fungaemia either with antifungal agents or by 
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removal of the catheter [ l ,  21. Most reported 
cases of catheter-related fungaemia have involved 
patients with underlying neoplastic disease. We 
report a case of catheter-related Rhodotorula sepsis, 
which was life-threatening and involved a patient 
without a neoplasm or apparent compromise of 
host immunity. 
Case history 
A 30-year-old woman was admitted to the Uni- 
versity of Michigan Medical Center in February 
1990 with a several day history of increasing 
abdominal pain, nausea, vomiting, and fever 
(40.0"C). In 1987, the patient had been diag- 
nosed as having familial visceral neuropathy 
manifested as chronic idiopathic intestinal 
pseudo-obstruction with intermittent nausea, 
vomiting, postprandial abdominal pain, and a 
weight loss from 59.1 to 38.2 kg over the two 
years prior to diagnosis [6]. The patient remained 
symptomatic during a brief trial of enteral feeding 
combined with cisapride, and thus hyperaliment- 
ation via a permanent indwelling Hickman cath- 
eter was initiated. She did well on total parenteral 
nutrition, such that she was able to maintain her 
weight at or above 53.2 kg, and her serum albu- 
min rose from a value of 2.2 g dl-' at the time 
of diagnosis to 3.7 g dl-' at the time of this 
admission. Her Hickman catheter had most 
recently been replaced in September 1989 in 
conjunction with antibiotic therapy for a cath- 
eter-associated infection. 
Upon admission, the patient was found to be 
in no acute distress. Blood pressure was 
l06/60 mmHg, pulse 108 beats/min, and tem- 
perature 38.4 "C. Physical examination showed 
mild erythema and induration of the skin sur- 
rounding the catheter site, but was otherwise 
unremarkable. The white blood cell count (WBC) 
was 9700mm-3, and haemoglobin was 12.7g 
dl-', stable from previous values. Evidence for 
mild cholestasis was attributed to central hyper- 
alimen tation. 
Based upon the history and several previous 
presentations of catheter-associated infection, a 
presumptive diagnosis of line-related infection 
was made. Multiple blood cultures were drawn, 
both via the catheter and peripherally, and ther- 
apy with vancomycin and ceftazidime was 
initiated. Within two days, blood cultures 
obtained both peripherally and from the catheter 
were found to be growing methicillin-sensitive 
coagulase-negative staphylococci. Ceftazidime 
was discontinued, and vancomycin was changed 
to cefazolin. The patient defervesced and subjec- 
tively improved, and the indwelling catheter was 
retained in place. 
Within four days, the original blood culture 
drawn from a peripheral vein was found to be 
growing a yeast identified as Rhodotorula rubra. 
However, because the original culture only grew 
a single colony of yeast and since there was 
continued clinical improvement with treatment 
for infection due to coagulase-negative staphylo- 
cocci, the yeast was interpreted to be a contami- 
nant, and no antifungal therapy was begun. 
Additional blood cultures were obtained from a 
peripheral site and through the Hickman cath- 
eter, the latter .yielding R. rubra (> 1000 
colonies ml- I )  within two days. Staphylococcus was 
never observed again in any blood cultures. 
Thirteen days after admission, the patient was 
afebrile and felt well. However, because a total 
of two blood cultures had yielded R.  rubra over 
eleven days, antifungal therapy with ampho- 
tericin B (MIC 0.05 pg ml-I) was initiated. The 
central catheter was not removed because of lack 
of intravenous access. She tolerated amphotericin 
B well in escalating doses to 25 mg daily and 
remained afebrile. 
On the 21st hospital day, the patient developed 
a temperature of 39.9"CY with a pulse of 160 
beatslmin, respirations of 28/min, and blood 
pressure of 52/30 mmHg. Intravenous fluids and 
pressors including dopamine and norepinephrine 
were given. The Hickman catheter was removed, 
cefazolin was discontinued, and broad-spectrum 
antibacterials, consisting of vancomycin and gen- 
tamicin, were initiated. The next day piperacillin 
was added to the antimicrobial regimen. That 
same day she suffered a cardiopulmonary arrest, 
but was successfully resuscitated, intubated, and 
begun on mechanical ventilation. Later that day, 
two additional blood cultures, obtained through 
the catheter one week earlier, yielded R. rubra 
(30 and 15 colonies/ml, respectively). Ampho- 
tericin B was increased to 45 mg daily 
(0.85 mg kg-' daily) and flucytosine (MIC 
0.2 pg ml-') was added at a dose of 1500 mg 
every 6 h. 
The WBC rose to 19,600mm-3, with 47% 
segmented neutrophils and 40% bands, and sub- 
sequently peaked at 37,200 111x11~~. Bilateral 
diffuse air-space disease, consistent with adul t 
respiratory distress syndrome, was noted on chest 
roentgenograms. For 8 days, the patient required 
the use of pressors to maintain adequate systemic 
blood pressure. She remained critically ill for over 
one month with daily maximal temperature 
exceeding 37.8"C for 32 days. She gradually 
improved and was extubated after 38 days of 
ventilatory support. Amphotericin B was given 
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for 29 days (total dose 1121 mg) and flucytosine 
was given for 21 days. After removal of the 
Hickman catheter, numerous blood cultures 
failed to grow R.  rubra or any other micro- 
organisms. This included three sets of blood cul- 
tures (anaerobic and aerobic) obtained from peri- 
pheral veins on the day of the patient’s acute 
decline (21st hospital day), as well as five 
additional sets of cultures obtained from peri- 
pheral sites over the next month. Additionally, 
one set of blood cultures obtained through the 
Hickman catheter just prior to its removal 
remained negative. Following extubation, the 
patient required continuing inpatient care and 
rehabilitation for more than six weeks. Another 
Hickman catheter was placed, and she was dis- 
charged from the hospital 107 days after 
admission. No further infection with R.  rubra has 
been observed. 
Mycology 
Blood cultures were performed with a Du Pont 
ISOSTAT microbial system (E. I. du Pont de 
Nemours & Company, Wilmington, DE, USA) 
with the sediment plated on chocolate agar. In 
order to enhance the isolation of fungi following 
the initial positive culture for Rhodotorula, sedi- 
ment from subsequent blood cultures was plated 
on Emmon’s modification of Sabouraud glucose 
agar and brain-heart infusion (BHI) agar with 
6% sheep’s blood added. The initial isolate was 
found to produce pink colonies on chocolate agar, 
suggesting that it was Rhodotorula. Microscopic 
examination disclosed oval-shaped, budding, 
encapsulated yeast. The sugar assimilation pat- 
tern on an API20C strip demonstrated that the 
yeast was R. rubra. 
Susceptibilities were performed using macro- 
broth dilution assays, with antibiotic medium 3 
broth (Difco Laboratories, Detroit, MI,  USA) 
used for amphotericin B testing and yeast nitrogen 
base broth (Difco) used for the flucytosine test- 
ing. The inoculum for each tube was 
1 x lo4 CFU ml-’ and incubation was performed 
at 37 “C for 18 h. The range of dilutions for both 
antifungals was 250 pg ml-’ to 0.01 pg ml-’ with 
the endpoint for both assays being the first clear 
tube. 
Discussion 
Yeast of the genus Rhodotorula belong to the family 
Cryptococcacae and are normal flora of skin and 
gastrointestinal tract [7, 81. They may also be 
found in soil, air, and water, in cheese and milk, 
and on common household items, such as shower 
curtains and bathtub grout. Members of the 
genus Rhodotorula resemble yeast of the genus 
Cryptococcus in that they are round to oval-shaped, 
demonstrate budding, form a capsule, produce 
urease, and are non-fermentative. The two genera 
may be differentiated by coral red pigment pro- 
duced by Rhodotorula and assimilation of inositol 
by Cryptococcus [8]. The most frequently isolated 
species is R .  rubra. 
Rhodotorula has been an uncommon infectious 
agent in humans, and animal studies have sug- 
gested that it possesses little pathogenicity [3, 91. 
With the increasing use of indwelling central 
venous catheters, however, more cases of fungae- 
mia have been observed. In  a recent review from 
a large metropolitan hospital specializing in the 
treatment of neoplastic disorders, 23 cases were 
felt to have clinically significant fungaemia associ- 
ated with permanent intravenous catheters [2]. 
Of these cases, 20 had an underlying neoplasm. 
Five patients were treated with catheter removal 
only, five received antifungal therapy only, and 
thirteen underwent catheter removal in addition 
to receiving antifungal therapy. All of these 
patients were reported to have survived without 
recurrence of Rhodotorula fungaemia. Earlier 
reports identified thirteen other cases of culture- 
proven Rhodotorula fungaemia, including one 
patient who died with Rhodotorula endocarditis 
found at  autopsy and another who died with 
R. rubra meningitis documented post mortem 
[ 1-4, 9-1 13. Several other deaths occurred but 
were not felt to be secondary to fungal infection. 
Of these earlier cases of fungaemia, four patients, 
including the patient with Rhodotorula endocar- 
ditis who later died, were reported to have experi- 
enced a clinically significant episode of 
hypotension, suggestive of Gram negative bacil- 
lary sepsis. Two of the three patients who survived 
septic shock recovered with removal of the 
indwelling device and no antifungal therapy [ 1, 
In vitro susceptibility testing of Rhodotorula to 
antifungal agents has been performed in a limited 
number of cases [ l ,  2, 4, 51. All isolates tested 
appear to be susceptible to flucytosine, ampho- 
tericin B, and ketonazole, with moderate suscepti- 
bility observed to miconazole and itraconazole. 
Although some isolates appear to be moderately 
susceptible to fluconazole, others have demon- 
strated M I C  values in excess of 100 pg ml-’ [2]. 
It is unlikely that coagulase-negative staphylo- 
cocci were the etiologic agents responsible for this 
patient’s life-threatening illness, since they were 
never isolated after the initial cultures and the 
113. 
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patient promptly responded to antistaphylococcal 
therapy. The septic syndrome developed nearly 
two weeks after coagulase-negative staphylococci 
had been isolated from the blood. Similarly, it is 
quite doubtful that the illness was caused by 
amphotericin B therapy, since the patient 
remained afebrile for the first week of therapy, 
developed fever without any correlation to 
amphotericin B administration, and remained 
febrile for weeks following the cessation of antifun- 
gal therapy. The  most likely etiology for the 
patient’s severe illness was infection with R.  rubra, 
which was isolated from one peripheral and three 
catheter-drawn blood cultures over a total period 
of two weeks. 
The patient described here differs in several 
respects from most of those reported previously 
with Rhodotorula fungaemia. First, this patient had 
no underlying neoplasm or apparent immuno- 
suppressive disorder. Second, the severity of illness 
observed was greater than in most other patients 
who have developed fungaemia with this yeast. 
Unlike most other patients previously reported, 
our patient was critically ill for many weeks, 
despite prolonged antifungal therapy and cath- 
eter removal one week after the initiation of 
amphotericin B. Several factors may have con- 
tributed to our patient’s severe illness. The delay 
of almost two weeks from the time that a blood 
culture specimen containing Rhodotorula was first 
obtained until amphotericin B treatment was 
begun, and the further delay until the infected 
catheter was removed, probably contributed to 
the severity of infection. Additionally, i t  is tempt- 
ing to speculate that her non-compromised 
immune status, exemplified by leukocytosis and 
left shift early in the course of infection, culmi- 
nated in a vigorous host response to the yeast, 
with effects on the host similar to those seen in 
Gram negative bacillary sepsis. 
Optimal management of patients with indwell- 
ing catheters infected with Rhodotorula has not 
been well defined. Pien et al. [ 11 noted that three 
of five survivors of Rhodotorula fungaemia had not 
received antifungal therapy and advised that 
infected intravenous devices be removed but that 
antifungal therapy be initiated only if fungaemia 
persisted [l]. More recently, Kiehn et al. [2] have 
advocated antifungal therapy in all cases of Rhodo- 
torula fungaemia, despite their observation that 
five patients survived with catheter removal 
alone. These authors also suggested that antifun- 
gal treatment without removal of the catheter 
may be appropriate in some cases. 
A recent review of catheter-associated fungae- 
mia, in which Candida species accounted for over 
98% of cases, concluded that indwelling catheters 
should be removed in all instances of fungaemia, 
noting a negative outcome in nine of eleven cases 
(82%) in which antifungal therapy was given 
without catheter removal [ 121. Although con- 
clusions of that study were drawn largely on the 
basis of experience with Candida species (infections 
with Rhodotorula species were not observed), we 
believe that our experience with the patient 
described here illustrates the potential for severe, 
life-threatening illness due to Rhodotorula infection, 
similar to that seen with Candida fungaemia. 
Therefore, we advocate both removal of indwell- 
ing intravenous catheters infected with Rhodotorula 
and treatment with systemic antifungal agents. 
We believe this constitutes the most prudent 
approach to management of a relatively uncom- 
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